Merck Sharp And Dohme recalls

Merck Sharp And Dohme appears in 6 official U.S. recall notices indexed by RecallRadar, most recently on 2025-12-31.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp…
  FDA Drug · Class II · 2025-12-31 · Merck Sharp And Dohme
• Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 0706…
  FDA Drug · Class II · 2025-12-31 · Merck Sharp And Dohme
• Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx…
  FDA Drug · Class II · 2022-04-13 · Merck Sharp And Dohme
• Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only
  FDA Drug · Class I · 2021-11-10 · Merck Sharp And Dohme
• Zerbaxa (ceftolozane and tazobactam) 1.5g per vial for injection, Single-Dose vial, Rx only, Manuf. for: Merck Sharp & Dohme Corp. a subsid…
  FDA Drug · Class II · 2021-01-13 · Merck Sharp And Dohme
• Bottles with cracked caps containing Temodar® (Temozolomide) and Temozolomide (generic) capsules
  CPSC · 2015-08-19 · Merck Sharp And Dohme